What You Should Know:
– An innovative ambient artificial intelligence (AI) platform holds significant promise for easing the burden of clinical documentation for healthcare providers, according to a new study from researchers at Sutter Health.
–…
Continue Reading
What You Should Know:
– Houston Methodist announced its pilot of Ambience Healthcare’s new AI notetaking solutions for emergency and inpatient care – some of the most complex, high-burnout areas of medicine.
– Ambience’s AI is…
Continue Reading
The climate crisis underscores the need for weather-based predictive analytics in healthcare, as weather factors contribute to ~11% of the global stroke burden. Therefore, we developed machine learning models using locoregional weather data to…
Continue Reading
What You Should Know:
– Nabla, an ambient AI assistant for clinicians, today announced an expanded partnership with Neighborhood Healthcare, a prominent Federally Qualified Health Center (FQHC) serving nearly 100,000 patients annually across California’s San…
Continue Reading
The rapid increase in patient portal messaging has heightened the workload for primary care physicians (PCPs), contributing to burnout. The use of generative artificial intelligence (AI) to draft responses to patient messages has shown…
Continue Reading
AI and digital technologies are critical to addressing the ever-expanding burden of dementia, write Professor Dag Aarsland and Dr Antonio Ruiz-Gonzalez
Dementia, caused by Alzheimer’s disease in most cases, is a growing crisis for the…
What You Should Know:
– Ascertain, a healthcare technology company focused on empowering care teams with artificial intelligence (AI) raises $10M in Series A funding round led by Deerfield Management, featuring strategic participation from Northwell…
Continue Reading
What You Should Know:
– Cancer patients don’t just fight the disease – they fight the system. Today, life-saving treatments are routinely delayed by days or even weeks due to manual, error-prone workflows
– To solve this, RISA Labs has…
Continue Reading
What You Should Know:
– Eli Lilly and Company announced positive topline Phase 3 results from ACHIEVE-1, a study evaluating the safety and efficacy of orforglipron compared to placebo in adults with type 2 diabetes…
Continue Reading
The White House Office of Management and Budget (OMB) released two memos directed to the heads of all executive branch departments and agencies establishing policies on federal AI use and purchase of AI in…
Continue Reading
